Analyst Recommendations

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for NDRBF on July 2, 2024 12:30PM ET. The previous analyst recommendation was Equal-Weight.NDRBF was trading at $4.5 at issue of the...

July 2, 2024   

Morgan Stanley analyst issues UNDERWEIGHT recommendation for GVDNY on July 2, 2024 12:28PM ET. The previous analyst recommendation was Underweight.GVDNY was trading at $94.21 at issue of the...

July 2, 2024   GVDNY -0.37%

Morgan Stanley analyst issues UNDERWEIGHT recommendation for SVNLY on July 2, 2024 12:29PM ET. The previous analyst recommendation was Underweight.SVNLY was trading at $4.76 at issue of the...

July 2, 2024   SVNLY -1.82%

H.C. Wainwright analyst issues BUY recommendation for PCRX on July 2, 2024 12:36PM ET. The previous analyst recommendation was Buy.PCRX was trading at $21.91 at issue of the...

July 2, 2024   PCRX 2.14%

Keefe, Bruyette & Woods analyst issues UNDERPERFORM recommendation for STC on July 2, 2024 10:01AM ET. The previous analyst recommendation was Underperform.STC was trading at $61.46 at issue...

July 2, 2024   STC 0.95%

Stephens analyst issues MARKET PERFORM recommendation for STC on July 2, 2024 10:01AM ET. The previous analyst recommendation was Market Perform.STC was trading at $61.46 at issue of...

July 2, 2024   STC 0.95%

Cowen & Co. analyst issues BUY recommendation for XOM on July 2, 2024 10:15AM ET. The previous analyst recommendation was Buy.XOM was trading at $114.455 at issue of...

July 2, 2024   XOM 1.15%

Wells Fargo analyst issues MARKET PERFORM recommendation for EXPE on July 2, 2024 10:01AM ET. The previous analyst recommendation was Market Perform.EXPE was trading at $122.225 at issue...

July 2, 2024   EXPE -1.70%

Wedbush analyst issues UNDERPERFORM recommendation for EXPE on July 2, 2024 10:01AM ET. The previous analyst recommendation was Underperform.EXPE was trading at $122.225 at issue of the analyst...

July 2, 2024   EXPE -1.70%

Canaccord Genuity analyst issues BUY recommendation for KRMD on July 2, 2024 10:05AM ET. The previous analyst recommendation was Buy.KRMD was trading at $2.25 at issue of the...

July 2, 2024   KRMD -0.45%